| 查看: 1097 | 回复: 22 | |||
| 当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖 | |||
[交流]
审稿意见回来后,如何处理不合理的返修意见?
|
|||
|
我之前投了运筹优化领域的一个期刊ejor,第一轮审稿意见回来后,有三个专家,我按照他们的意见做了相应的修改并提交了回去,现在结果又回来了,第二和三个审稿人的意见是可以接收了。但是第一个审稿人reviewer 1又提出了两个意见,这两个意见我认为是不能改的,我个人认为是reviewer 1没正确理解文章所做出的不合理意见。然后主编看到这种情况,就有了以下的决定。 主编: As you can see from the reports enclosed, the referees hold conflicting views on your paper. In these circumstances, it has been decided that your paper should be reconsidered for publication in the EUROPEAN JOURNAL OF OPERATIONAL RESEARCH if you will revise it to meet the enclosed referees' comments. (You may wish to argue that some comments are invalid). The most critical comments from Reviewer #1 made me doubt whether I should reconsider your paper, so I need convincing arguments from you and a thorough revision to counterbalance the critical comments. When resubmitting the revised paper, please provide your answers to the referees, separately for each referee. Please also ensure that you have cited recent and relevant publications in EJOR and other OR journals. I am most grateful for your interest and hope that you will not be deterred from resubmitting this paper in the very near future. You are advised to revise and resubmit your manuscript by the Mar 09, 2026. After this time the review process of this submission will be terminated, by withdrawing your paper from the Editorial Manager, and the revised paper will have to be submitted as a new submission. Reviewer #2: All my comments have been suitably addressed. I recommend that this paper be accepted in its present version. I congratulate the authors on a very interesting paper with a solid contribution. Reviewer #3: Thank you for your careful and meticulous revision. In this revision, I find that the manuscript has fully responded to the reviewer comments from the first round. The writing and flow has been substantially improved, and the motivations, contributions, literature review, and conclusions were carefully revised. The parameter settings for the case studies have also been sufficiently justified, and I appreciate the additional figures and plots to help the audience understand the results. The quality of the article has been substantially improved after addressing all the comments from the reviewers. I have no remaining requests for revision, and I appreciate your thorough and professional response. Good luck with your future research. Reviewer #1: Thanks for the efforts that the authors have put into revising the manuscript. However, I feel that my earlier concerns have not been fully addressed. And in my view, the current version has not yet reached the standard required for publication in EJOR. Below, I outline the major points that still need attention. 意见1:。。。。。。 意见2:。。。。。。意见1和2我就不详细列出来了,因为涉及具体的文章内容。 Overall, I like the method proposed by the authors and I can see the value, however, I find that both the depth of analysis and the clarity of presentation still require substantial improvement. 现在我的可选行动方案是: (1) 我不会再修改了,但是给主编发个邮件,解释Reviewer #1的两个个人认为不合理的意见,然后改投另一个期刊。 (2) 我不可能再大修了,但会做一些句子连贯上的小修,然后在Response letter写出个人认为的修改意见的不合理之处,然后再重新提交ejor,我估计会不被接受,所以这时候是不是系统上只有这一次新的submission的拒绝记录(如果不被接受)?因为之前的submission和Reviewer2和3的意见都被删除了? 如果我采取方案2,然后被拒绝后再去投其它omaga一类的期刊会不会有什么影响? 谢谢~ |
» 猜你喜欢
本人考085602 化学工程 专硕
已经有4人回复
伙伴们,祝我生日快乐吧
已经有22人回复
调剂
已经有7人回复
289求调剂
已经有5人回复
一志愿武理314求调剂
已经有6人回复
欢迎申博同学联系
已经有5人回复
288求调剂
已经有4人回复
国自科面上基金字体
已经有4人回复
梁成伟老师课题组欢迎你的加入
已经有6人回复
274求调剂
已经有3人回复
» 抢金币啦!回帖就可以得到:
西湖大学工学院智能微型机器人实验室博士后招聘启事
+4/264
重庆医科大学神经科学中心/病生与生理系诚邀海内外优秀博士加盟博士后队伍(长期)
+1/88
物理学 调剂
+1/87
化学化工学院 招收化工、化学、材料等相关方向研究生(学硕、专硕都有调剂名额)
+1/83
博士后出站经验请教
+1/83
南开大学罗景山教授课题组招收2026年入学博士生(光/电催化方向)
+2/40
0854电子信息调剂,集成电路,芯片方向,闽南师范大学光电芯片研发实验室
+1/37
2026年工科硕士调剂-上海大学全国重点实验室团队-材料数据挖掘方向-研究生3-5人
+1/35
纺织科学与工程、材料化工方向招收研究生
+1/31
江西理工大学稀土学院/国家稀土功能材料创新中心招收博士研究生和调剂硕士研究生
+1/18
山东省植物基蛋白技术创新中心课题组联合培养硕士研究生招募启事
+1/17
学术/专业硕士调剂——化学、资源与环境
+1/16
【全奖招生】北师港浸大ESLAS实验室招收密码工程/网络安全/计算机视觉博士/博士后
+1/13
海南大学徐月山老师招生2026年第二批博士名额2~3个(高端设备开发方向)
+1/8
复旦大学集成电路学院程增光课题组急聘科研助理
+1/7
课题组招收环境及相关专业调剂硕士研究生(欢迎优秀学生加入)
+1/5
国家杰青低维材料与器件力学团队2026年招收博士研究生
+1/4
食品调剂-总分291-有中核论文导师一作、本人二作-一志愿南昌大学学硕-介绍详细
+1/3
095400 森林培育 303求调剂
+1/2
PD-1抗体如何拓展抗病毒治疗新 frontier?
+1/1
22楼2025-09-14 14:20:51
3楼2025-09-13 18:21:30
9楼2025-09-13 19:47:59
简单回复
tzynew2楼
2025-09-13 18:16
回复
BayesInter(金币+1): 谢谢参与
o 发自小木虫手机客户端
2025-09-13 18:25
回复
zusn6楼
2025-09-13 18:48
回复
我才是肖牧冲7楼
2025-09-13 19:18
回复
BayesInter(金币+1): 谢谢参与
。 发自小木虫手机客户端
elainzaizai10楼
2025-09-13 19:54
回复
没有感觉的鱼12楼
2025-09-13 20:57
回复
BayesInter(金币+1): 谢谢参与
。 发自小木虫IOS客户端
明天会更好12313楼
2025-09-13 21:05
回复
BayesInter(金币+1): 谢谢参与
。 发自小木虫手机客户端
ygxzxd14楼
2025-09-13 21:27
回复
BayesInter(金币+1): 谢谢参与
?? 发自小木虫IOS客户端














回复此楼
送红花一朵